Neuropsychiatric Disease and Treatment

Official journal of the International Neuropsychiatric Association (INA) Indexed: – The American Psychological Association’s PsycINFO database- EmBase, Scopus and the Elsevier Bibliographic databases- American Chemical Society’s Chemical Abstracts Service (CAS)- PubMed (files to appear soon)ISSN 1176-6328 (Print)ISSN 1178-2021 (Online)An international, peer-reviewed journal of clinical therapeutics and pharmacology focusing on concise rapid reporting of clinical or pre-clinical studies on a range of neuropsychiatric and neurological disorders.Key benefitsConcise rapid reporting Clinical therapeutics and pharmacology focus Neuropsychiatric and neurological disorders Aims and scopeSubject areas include:Clinical studies throughout the drug development processSafety, outcome, and economic studiesPsychiatric illness including depression, schizophrenia, and anxiety disordersNeurological disorders including Parkinson’s disease, epilepsy, pain, Alzheimer’s disease, and othersContributions in basic and preclinical science are welcome where they elucidate disease processes in humans or novel treatment modalities.These areas are addressed through:Original clinical research (full papers and concise rapid reports)ReviewsBasic science studies that shed light on disease pathogenesis or the mode of action of treatmentsSystematic reviews of individual new or important drugs. Such reviews will normally be commissionedExpert opinion and commentary.